Azitra (AZTR) Asset Utilization Ratio (2023 - 2025)

Azitra (AZTR) reported Asset Utilization Ratio of 0.0 for Q2 2025, down 98.15% on a YoY basis from 0.08 in Q2 2024, and up 73.73% quarter-over-quarter from 0.0 in Q4 2024.

Azitra (AZTR) Asset Utilization Ratio (2023 - 2025) Analysis & Trends

Azitra has reported Asset Utilization Ratio for 3 years, with the latest figure at 0.0 in Q2 2025.

  • For the quarter ending Q2 2025, Asset Utilization Ratio fell 98.15% year-over-year to 0.0; the trailing twelve-month figure through Jun 2025 stood at 0.0 (down 98.15% YoY), and the FY2024 full-year result was 0.0, down 98.92% from the prior year.
  • Asset Utilization Ratio for Q2 2025 stood at 0.0, up from 0.0 in the prior quarter.
  • The five-year high for Asset Utilization Ratio was 0.11 in Q4 2023, with the low at 0.0 in Q4 2024.
  • Historically, Asset Utilization Ratio has averaged 0.05 across 3 years, with a median of 0.07 in 2023.
  • The largest YoY upside for Asset Utilization Ratio was 80.27% in 2024 against a maximum downside of 99.2% in 2024.
  • Azitra's Asset Utilization Ratio stood at 0.11 in 2023, then sank by 99.2% to 0.0 in 2024, then surged by 73.73% to 0.0 in 2025.
  • The last three Asset Utilization Ratio figures came in at 0.0 (Q2 2025), 0.0 (Q4 2024), and 0.01 (Q3 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 0.55
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.60
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 1,422.00
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 0.47
9 Abivax 91.96 Bn 91.96 Bn - -
10 Azitra 20,900.00 20,900.00 - -

Historic Data

Download Data
DateValue
Jun 30, 2025 0.00
Dec 31, 2024 0.00
Sep 30, 2024 0.01
Jun 30, 2024 0.08
Mar 31, 2024 0.10
Dec 31, 2023 0.11
Sep 30, 2023 0.07